152 related articles for article (PubMed ID: 31583001)
1. IL-17 is Aberrantly Overexpressed Among Under-treatment
Mohammadi S; Sedighi S; Memarian A
Iran J Pathol; 2019; 14(3):236-242. PubMed ID: 31583001
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid-induced leucine zipper expression is associated with response to treatment and immunoregulation in systemic lupus erythematosus.
Mohammadi S; Ebadpour MR; Sedighi S; Saeedi M; Memarian A
Clin Rheumatol; 2017 Aug; 36(8):1765-1772. PubMed ID: 28601944
[TBL] [Abstract][Full Text] [Related]
3. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
4. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus.
Shah K; Lee WW; Lee SH; Kim SH; Kang SW; Craft J; Kang I
Arthritis Res Ther; 2010; 12(2):R53. PubMed ID: 20334681
[TBL] [Abstract][Full Text] [Related]
6. Principal component analysis reveals disconnect between regulatory cytokines and disease activity in Systemic Lupus Erythematosus.
Raymond WD; Eilertsen GØ; Nossent J
Cytokine; 2019 Feb; 114():67-73. PubMed ID: 30551949
[TBL] [Abstract][Full Text] [Related]
7. Increased Macroautophagy in Interferon-Gamma-Producing T Cells from Patients with Newly Diagnosed Systemic Lupus Erythematosus.
Luo XY; Yuan JL; Liu J; Luo CN; Yang MH; Wei Q; Yang M; Chen Y; Liu Y; Yuan GH
Chin Med J (Engl); 2018 Jul; 131(13):1527-1532. PubMed ID: 29941705
[TBL] [Abstract][Full Text] [Related]
8. Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus.
Yang XY; Wang HY; Zhao XY; Wang LJ; Lv QH; Wang QQ
J Clin Immunol; 2013 May; 33(4):767-74. PubMed ID: 23435610
[TBL] [Abstract][Full Text] [Related]
9. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.
Lit LC; Wong CK; Li EK; Tam LS; Lam CW; Lo YM
J Rheumatol; 2007 Jan; 34(1):89-96. PubMed ID: 17117487
[TBL] [Abstract][Full Text] [Related]
10. Immunoregulation therapy changes the frequency of interleukin (IL)-22+ CD4+ T cells in systemic lupus erythematosus patients.
Zhao L; Ma H; Jiang Z; Jiang Y; Ma N
Clin Exp Immunol; 2014 Jul; 177(1):212-8. PubMed ID: 24635166
[TBL] [Abstract][Full Text] [Related]
11. Decreased plasma IL-22 levels and correlations with IL-22-producing T helper cells in patients with new-onset systemic lupus erythematosus.
Lin J; Yue LH; Chen WQ
Scand J Immunol; 2014 Feb; 79(2):131-6. PubMed ID: 24313261
[TBL] [Abstract][Full Text] [Related]
12. Type I interferon and T helper 17 cells co-exist and co-regulate disease pathogenesis in lupus patients.
Biswas PS; Aggarwal R; Levesque MC; Maers K; Ramani K
Int J Rheum Dis; 2015 Jul; 18(6):646-53. PubMed ID: 25960196
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
14. Role of T helper 17 cells in the pathogenesis of systemic lupus erythematosus.
Abou Ghanima AT; Elolemy GG; Ganeb SS; Abo Elazem AA; Abdelgawad ER
Egypt J Immunol; 2012; 19(2):25-33. PubMed ID: 23885404
[TBL] [Abstract][Full Text] [Related]
15. Interferon-γ Is Associated with Cerebral Atrophy in Systemic Lupus Erythematosus.
Postal M; Ruocco HH; Brandão CO; Costallat LTL; Silva L; Cendes F; Appenzeller S
Neuroimmunomodulation; 2017; 24(2):100-105. PubMed ID: 28848179
[TBL] [Abstract][Full Text] [Related]
16. Could GILZ Be the Answer to Glucocorticoid Toxicity in Lupus?
Flynn JK; Dankers W; Morand EF
Front Immunol; 2019; 10():1684. PubMed ID: 31379872
[TBL] [Abstract][Full Text] [Related]
17. Increased interleukin‑9 and CD4+IL-9+ T cells in patients with systemic lupus erythematosus.
Ouyang H; Shi Y; Liu Z; Feng S; Li L; Su N; Lu Y; Kong S
Mol Med Rep; 2013 Mar; 7(3):1031-7. PubMed ID: 23291628
[TBL] [Abstract][Full Text] [Related]
18. Cytokines in systemic lupus erythematosus: far beyond Th1/Th2 dualism lupus: cytokine profiles.
Guimarães PM; Scavuzzi BM; Stadtlober NP; Franchi Santos LFDR; Lozovoy MAB; Iriyoda TMV; Costa NT; Reiche EMV; Maes M; Dichi I; Simão ANC
Immunol Cell Biol; 2017 Oct; 95(9):824-831. PubMed ID: 28649995
[TBL] [Abstract][Full Text] [Related]
19. The Expression of P2X7 Receptor on Th1, Th17, and Regulatory T Cells in Patients with Systemic Lupus Erythematosus or Rheumatoid Arthritis and Its Correlations with Active Disease.
Li M; Yang C; Wang Y; Song W; Jia L; Peng X; Zhao R
J Immunol; 2020 Oct; 205(7):1752-1762. PubMed ID: 32868411
[TBL] [Abstract][Full Text] [Related]
20. Altered frequency of Th17 and Treg cells in new-onset systemic lupus erythematosus patients.
Chen M; Chen X; Wan Q
Eur J Clin Invest; 2018 Nov; 48(11):e13012. PubMed ID: 30079446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]